ArticleCureus2026
Recreational Cannabis Legalization and Traffic Fatality Rates in the United States, 2005-2024: An Imputation-Based Difference-in-Differences Event Study.
Article in Cureus, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background Recreational cannabis legalization has expanded rapidly in the United States; however, population-level analyses examining its association with traffic fatalities yield mixed results. These heterogeneous findings arise from methodological limitations, including short follow-up windows, a focus on early-adopting states, and methods that do not adequately account for staggered policy adoption. Methods We analyzed a 50-state panel (2005-2024) using an imputation-based difference-in-differences estimator designed for staggered policy adoption. The outcome was the log traffic fatality rate per one billion vehicle miles traveled. We estimated effects from the year of legalization through year four, with four pre-treatment years to assess parallel trends. The primary model included state- and year-fixed effects and controlled for demographic composition, weather (precipitation and annual average temperature), unemployment, traffic safety laws, and COVID-19 mortality. Sensitivity analyses estimated robustness by varying the sample composition (excluding early adopters, pandemic years, and Florida), modifying the treatment definition (legalization effective date vs. retail sales start), and including Poisson count-model replication. Results The panel included 1,000 state-year observations; the primary difference-in-differences analysis used 951 observations meeting all inclusion criteria. Post-legalization, traffic fatality rates increased by approximately 4.2% in the legalization year (τ=0: 0.041; 95% confidence interval (CI): 0.006, 0.077; p=0.022) and 6.1% by year four (τ=4: 0.060; 95% CI: 0.007, 0.112; p=0.027). Pre-treatment trends were parallel between treatment and control groups (joint test: χ²(4)=4.93; p=0.295), and the post-legalization increase was statistically significant overall (joint test: χ²(5)=11.56; p=0.041). Findings remained consistent when excluding early-adopting states, pandemic years, or Florida, and a Poisson count-model replication produced the same direction and magnitude. When treatment was instead indexed to the start of retail sales, no increase was observed in the first year (τ = 0: 0.011; 95% CI: -0.027, 0.050), and the overall post-retail joint test did not reach conventional significance (
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.